Literature DB >> 12021177

Complex 5' genomic structure of the human prolactin receptor: multiple alternative exons 1 and promoter utilization.

Zhang-Zhi Hu1, Li Zhuang, Jianping Meng, Chon-Hwa Tsai-Morris, Maria L Dufau.   

Abstract

Transcription of the prolactin receptor (PRLR) is under the control of multiple promoters. Following the recent demonstration of the human non-coding exon 1, hE1(N) (hE1(N1)) and the generic exon 1 hE1(3), we have identified their promoters and characterized four other novel human exons 1 (hE1(N2-5)) that are alternatively spliced to a common non-coding exon 2 in human tissues and breast cancer cells. Genomic regions containing these exons, and 5'-flanking and intronic sequences, were determined and their order was established in chromosome 5p14-13. Promoters utilized in the transcription of previously characterized PRLR exons 1 species hE1(3) (hPII) and hE1(N1) (hP(N1)) were found to employ distinct mechanisms for controlling hPRLR transcription. hPIII requires C/EBP beta and Sp1/Sp3 for basal transcriptional activity, while hP(N1) activity is conferred by domains containing an Ets element and an NR half-site. The complex promoter control system that governs transcription of the hPRLR in multiple tissues is of relevance for studies on the regulation of PRLR expression in physiological and pathological states.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021177     DOI: 10.1210/endo.143.6.8949

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Prolactin receptor gene polymorphisms are associated with gestational diabetes.

Authors:  Trang N Le; Sarah H Elsea; Roberto Romero; Tinnakorn Chaiworapongsa; Gary L Francis
Journal:  Genet Test Mol Biomarkers       Date:  2013-05-07

2.  Complex formation and interactions between transcription factors essential for human prolactin receptor gene transcription.

Authors:  Jung-Hoon Kang; Chon-Hwa Tsai-Morris; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2011-06-13       Impact factor: 4.272

Review 3.  Regulation of prolactin receptor levels and activity in breast cancer.

Authors:  G Swaminathan; B Varghese; S Y Fuchs
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

4.  Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor.

Authors:  Y-L Xie; S A Hassan; A M Qazi; C H Tsai-Morris; M L Dufau
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

5.  Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.

Authors:  Dan Zhao; Gui Ma; Xiaolin Zhang; Yuan He; Mei Li; Xueying Han; Liya Fu; Xue-Yuan Dong; Tamas Nagy; Qiang Zhao; Li Fu; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2016-04-20       Impact factor: 5.157

6.  Impact of subdomain D1 of the short form S1b of the human prolactin receptor on its inhibitory action on the function of the long form of the receptor induced by prolactin.

Authors:  J-H Kang; S A Hassan; P Zhao; C H Tsai-Morris; M L Dufau
Journal:  Biochim Biophys Acta       Date:  2014-04-13

Review 7.  What can we learn from rodents about prolactin in humans?

Authors:  Nira Ben-Jonathan; Christopher R LaPensee; Elizabeth W LaPensee
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

8.  A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.

Authors:  Sulggi A Lee; Christopher A Haiman; Noel P Burtt; Loreall C Pooler; Iona Cheng; Laurence N Kolonel; Malcolm C Pike; David Altshuler; Joel N Hirschhorn; Brian E Henderson; Daniel O Stram
Journal:  BMC Med Genet       Date:  2007-12-01       Impact factor: 2.103

9.  Dp412e: a novel human embryonic dystrophin isoform induced by BMP4 in early differentiated cells.

Authors:  Emmanuelle Massouridès; Jérôme Polentes; Philippe-Emmanuel Mangeot; Virginie Mournetas; Juliette Nectoux; Nathalie Deburgrave; Patrick Nusbaum; France Leturcq; Linda Popplewell; George Dickson; Nicolas Wein; Kevin M Flanigan; Marc Peschanski; Jamel Chelly; Christian Pinset
Journal:  Skelet Muscle       Date:  2015-11-14       Impact factor: 4.912

10.  Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.

Authors:  Raghuveer Kavarthapu; Chon-Hwa Tsai Morris; Maria L Dufau
Journal:  Oncotarget       Date:  2014-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.